(H41E) HSBC MSCI Emerging Markets - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE000NVVIF88 • Global Emerging Markets Equity

H41E: Stocks, Bonds, Emerging Markets, Value, ESG, ETF

The HSBC MSCI Emerging Markets Value ESG UCITS ETF USD (Acc) EUR (Ticker: H41E) is an exchange-traded fund listed on XETRA, designed to track the performance of the Morningstar EM TME NR USD Index. This index focuses on emerging market equities, incorporating both value and ESG (Environmental, Social, and Governance) criteria. The fund is structured as a UCITS-compliant ETF, offering exposure to a diversified portfolio of emerging market stocks that meet specific value and sustainability standards.

Ticker Symbol: H41E | Exchange: XETRA | Type: ETF | Country Origin: Germany | ETF Category: Global Emerging Markets Equity

Average Volume 20d: 4,733 | Last Price: 13.51 | SMA 20: 14.01 | SMA 50: 13.76 | SMA 200: 13.26 | ATR: 0.14

AUM: 82.01M EUR

The funds technical indicators suggest a recent downtrend, with the last price of 13.51 sitting below its SMA 20 (14.01) and SMA 50 (13.76), while remaining slightly above its SMA 200 (13.26). The Average True Range (ATR) of 0.14 indicates moderate volatility. The average daily trading volume of 4,733 shares reflects relatively low liquidity compared to larger ETFs.

From a fundamental perspective, the funds Assets Under Management (AUM) of 82.01M EUR indicate a modestly sized ETF, which may appeal to investors seeking targeted exposure to emerging markets with a value and ESG tilt. The Morningstar EM TME NR USD Index underlying this ETF is designed to capture the performance of undervalued stocks in emerging markets, adjusted for ESG considerations.

3-Month Forecast: Based on and , the ETF is likely to face headwinds in the near term due to the downward trend indicated by its SMA 20 and SMA 50. However, the funds ESG focus and value orientation could attract inflows if emerging market equities rebound. Technically, if the price breaks above its SMA 50 (13.76), it could signal a potential recovery. Fundamentally, emerging market performance will depend on global risk sentiment, U.S. dollar strength, and monetary policy trends in key emerging economies.

Additional Sources for H41E ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

H41E ETF Overview

Market Cap in USD 89m
Category Global Emerging Markets Equity
IPO / Inception 2022-12-07

H41E ETF Ratings

Growth 5y 56.2%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -13.6
Analysts -
Fair Price Momentum 12.66 EUR
Fair Price DCF -

H41E Dividends

No Dividends Paid

H41E Growth Ratios

Growth Correlation 3m 15.7%
Growth Correlation 12m 83.3%
Growth Correlation 5y 91.3%
CAGR 5y 11.41%
CAGR/Max DD 5y 1.18
Sharpe Ratio 12m 0.23
Alpha 3.26
Beta 0.66
Volatility 13.99%
Current Volume 0.1k
Average Volume 20d 1.4k
What is the price of H41E stocks?
As of March 15, 2025, the stock is trading at EUR 13.42 with a total of 59 shares traded.
Over the past week, the price has changed by +0.03%, over one month by -4.25%, over three months by -1.27% and over the past year by +10.20%.
Is HSBC MSCI Emerging Markets a good stock to buy?
Partly, yes. Based on ValueRay Analyses, HSBC MSCI Emerging Markets (XETRA:H41E) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.16 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of H41E as of March 2025 is 12.66. This means that H41E is currently overvalued and has a potential downside of -5.66%.
Is H41E a buy, sell or hold?
HSBC MSCI Emerging Markets has no consensus analysts rating.
What are the forecast for H41E stock price target?
According to ValueRays Forecast Model, H41E HSBC MSCI Emerging Markets will be worth about 14.1 in March 2026. The stock is currently trading at 13.42. This means that the stock has a potential upside of +5.37%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 14.1 5.4%